Advanced in Magnesium Deficiency

Dominik P. Modest

Berlin, BE, DE 
Advanced in Magnesium Deficiency
Berlin, BE, DE 
OverviewLocationsClinical Research

Overview

Dominik Modest practices in Berlin, Germany. Mr. Modest is rated as an Advanced expert by MediFind in the treatment of Magnesium Deficiency. His top areas of expertise are Colorectal Cancer, Cholangiocarcinoma (Bile Duct Cancer), Lung Metastases, Pancreaticoduodenectomy, and Hepatectomy.

His clinical research consists of co-authoring 177 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Magnesium Deficiency.

Gender
Male

Locations

Berlin, BE, Germany
Other Locations
Heidelberg, BW, Germany
Essen, NW, Germany
Mitte, BE 10117, Germany
Munich, BY, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Global Multicenter Randomized Placebo-Controlled Phase 3 Trial To Compare The Efficacy And Safety Of Fruquintinib Plus Best Supportive Care To Placebo Plus Best Supportive Care In Patients With Refractory Metastatic Colorectal Cancer
A Global Multicenter Randomized Placebo-Controlled Phase 3 Trial To Compare The Efficacy And Safety Of Fruquintinib Plus Best Supportive Care To Placebo Plus Best Supportive Care In Patients With Refractory Metastatic Colorectal Cancer
Enrollment Status: Completed
Publish Date: April 04, 2025
Intervention Type: Drug
Study Drug: Fruquintinib
Study Phase: Phase 3
Screening Platform of the EORTC for Clinical Trials in Advanced Colorectal Cancer SPECTAcolor
Screening Platform of the EORTC for Clinical Trials in Advanced Colorectal Cancer SPECTAcolor
Enrollment Status: Completed
Publish Date: July 07, 2022
Intervention Type: Genetic
View 1 Less Clinical Trial

177 Total Publications

Individual Patient Data Meta-Analysis of Consensus Molecular Subtypes as Biomarkers of First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer.
Individual Patient Data Meta-Analysis of Consensus Molecular Subtypes as Biomarkers of First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Modest's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile